Molecular mechanisms associated with the metastatic nature of SCLC include the overexpression of nuclear factor I B (NFIB) and MYC proto-oncogene, as well as neuroendocrine differentiation markers such as neural cell adhesion molecule (NCAM), which collectively enhance metastatic capacity [13,15]. The gene discussed is CHL1; the disease is small cell lung carcinoma.